HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency

Retrovirology

Volumn 9, Issue , 2012, Pages

  Santoni, Federico A ^a   Guerra, Jessica ^a   Luban, Jeremy ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Embryonic stem cell; Endogenous retrovirus; HERV H; Induced pluripotent stem cell; Long non coding RNA; Pluripotency

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VIRUS RNA;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELLULAR PARAMETERS; EMBRYO; EMBRYONIC STEM CELL; ENDOGENOUS RETROVIRUS; GENETIC TRANSCRIPTION; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN ENDOGENOUS RETROVIRUS H; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENCY; PLURIPOTENT STEM CELL; RETROPOSON; RNA SEQUENCE;

ALGORITHMS; BINDING SITES; BIOLOGICAL MARKERS; CHROMATIN; EMBRYONIC STEM CELLS; ENDOGENOUS RETROVIRUSES; GENE EXPRESSION REGULATION; HISTONES; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; ORGAN SPECIFICITY; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, VIRAL; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS; STAT1 TRANSCRIPTION FACTOR; TERMINAL REPEAT SEQUENCES;

HUMAN ENDOGENOUS RETROVIRUS H; IPS;

EID: 84871215627     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-111     Document Type: Article

References (54)

1. Stoye JP. Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol 2012, 10:395-406.
2. Weiss RA. The discovery of endogenous retroviruses. Retrovirology 2006, 3:67. 10.1186/1742-4690-3-67, 1617120, 17018135.
3. Subramanian RP, Wildschutte JH, Russo C, Coffin JM. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology 2011, 8:90. 10.1186/1742-4690-8-90, 3228705, 22067224.
4. Stengel A, Roos C, Hunsmann G, Seifarth W, Leib-Mosch C, Greenwood AD. Expression profiles of endogenous retroviruses in Old World monkeys. J Virol 2006, 80:4415-4421. 10.1128/JVI.80.9.4415-4421.2006, 1472034, 16611901.
5. Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang XY, Edouard P, Howes S, et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000, 403:785-789. 10.1038/35001608, 10693809.
6. Vargas A, Moreau J, Landry S, LeBellego F, Toufaily C, Rassart E, Lafond J, Barbeau B. Syncytin-2 plays an important role in the fusion of human trophoblast cells. J Mol Biol 2009, 392:301-318. 10.1016/j.jmb.2009.07.025, 19616006.
7. Mangeney M, Renard M, Schlecht-Louf G, Bouallaga I, Heidmann O, Letzelter C, Richaud A, Ducos B, Heidmann T. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci U S A 2007, 104:20534-20539. 10.1073/pnas.0707873105, 2154466, 18077339.
8. Coffin J, Hughes S, Varmus H. Retroviruses 1997, Cold Spring Harbor Laboratory Press, New York.
9. Muster T, Waltenberger A, Grassauer A, Hirschl S, Caucig P, Romirer I, Fodinger D, Seppele H, Schanab O, Magin-Lachmann C, et al. An endogenous retrovirus derived from human melanoma cells. Cancer Res 2003, 63:8735-8741.
10. Kolson DL, Gonzalez-Scarano F. Endogenous retroviruses and multiple sclerosis. Ann Neurol 2001, 50:429-430. 10.1002/ana.1235, 11601492.
11. Nexo BA, Christensen T, Frederiksen J, Moller-Larsen A, Oturai AB, Villesen P, Hansen B, Nissen KK, Laska MJ, Petersen TS, et al. The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1. PLoS One 2011, 6:e16652. 10.1371/journal.pone.0016652, 3032779, 21311761.
12. Petersen T, Moller-Larsen A, Thiel S, Brudek T, Hansen TK, Christensen T. Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis. J Neuroimmunol 2009, 215:108-116. 10.1016/j.jneuroim.2009.08.015, 19766328.
13. Karlsson H, Schroder J, Bachmann S, Bottmer C, Yolken RH. HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder. Mol Psychiatry 2004, 9:12-13. 10.1038/sj.mp.4001439, 14571258.
14. Young GR, Eksmond U, Salcedo R, Alexopoulou L, Stoye JP, Kassiotis G. Resurrection of endogenous retroviruses in antibody-deficient mice. Nature 2012, 491:774-778.
15. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, Erickson AL, Agrawal A, Spotts G, Hecht FM, et al. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 2007, 3:e165. 10.1371/journal.ppat.0030165, 2065876, 17997601.
16. SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, et al. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J Virol 2011, 85:6977-6985. 10.1128/JVI.00179-11, 3126607, 21525339.
17. van der Kuyl AC. HIV infection and HERV expression: a review. Retrovirology 2012, 9:6. 10.1186/1742-4690-9-6, 3311604, 22248111.
18. Santoni FA, Hartley O, Luban J. Deciphering the code for retroviral integration target site selection. PLoS Comput Biol 2010, 6:e1001008. 10.1371/journal.pcbi.1001008, 2991247, 21124862.
19. Santoni FA. EMdeCODE: a novel algorithm capable of reading words of epigenetic code to predict enhancers and retroviral integration sites and to identify H3R2me1 as a distinctive mark of coding versus non-coding genes. Nucl Acid Res 2012, in press.
20. Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M, Edsall LE, Kuan S, Luu Y, Klugman S, et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 2010, 6:479-491. 10.1016/j.stem.2010.03.018, 2867844, 20452322.
21. Guenther MG, Frampton GM, Soldner F, Hockemeyer D, Mitalipova M, Jaenisch R, Young RA. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 2010, 7:249-257. 10.1016/j.stem.2010.06.015, 3010384, 20682450.
22. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T, Euskirchen G, Bernier B, Varhol R, Delaney A, et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 2007, 4:651-657. 10.1038/nmeth1068, 17558387.
23. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, Kellis M, Marra MA, Beaudet AL, Ecker JR, et al. The NIH roadmap epigenomics mapping consortium. Nat Biotechnol 2010, 28:1045-1048. 10.1038/nbt1010-1045, 20944595.
24. Kunarso G, Chia NY, Jeyakani J, Hwang C, Lu X, Chan YS, Ng HH, Bourque G. Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat Genet 2010, 42:631-634. 10.1038/ng.600, 20526341.
25. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322. 10.1038/nature08514, 2857523, 19829295.
26. Wu JQ, Habegger L, Noisa P, Szekely A, Qiu C, Hutchison S, Raha D, Egholm M, Lin H, Weissman S, et al. Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing. Proc Natl Acad Sci U S A 2010, 107:5254-5259. 10.1073/pnas.0914114107, 2841935, 20194744.
27. Adli M, Zhu J, Bernstein BE. Genome-wide chromatin maps derived from limited numbers of hematopoietic progenitors. Nat Methods 2010, 7:615-618. 10.1038/nmeth.1478, 2924612, 20622861.
28. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560. 10.1038/nature06008, 2921165, 17603471.
29. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011, 144:439-452. 10.1016/j.cell.2010.12.032, 3063454, 21295703.
30. Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 2007, 25:15-30. 10.1016/j.molcel.2006.12.014, 17218268.
31. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837. 10.1016/j.cell.2007.05.009, 17512414.
32. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326. 10.1016/j.cell.2006.02.041, 16630819.
33. Celniker SE, Dillon LA, Gerstein MB, Gunsalus KC, Henikoff S, Karpen GH, Kellis M, Lai EC, Lieb JD, MacAlpine DM, et al. Unlocking the secrets of the genome. Nature 2009, 459:927-930. 10.1038/459927a, 2843545, 19536255.
34. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470:279-283. 10.1038/nature09692, 21160473.
35. Tada T, Tada M. Toti-/pluripotential stem cells and epigenetic modifications. Cell Struct Funct 2001, 26:149-160. 10.1247/csf.26.149, 11565807.
36. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676. 10.1016/j.cell.2006.07.024, 16904174.
37. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920. 10.1126/science.1151526, 18029452.
38. Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, Robertson M, Vrana J, Jones K, Grotewold L, Smith A. Nanog safeguards pluripotency and mediates germline development. Nature 2007, 450:1230-1234. 10.1038/nature06403, 18097409.
39. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642. 10.1016/S0092-8674(03)00393-3, 12787504.
40. Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 2005, 6:872-884. 10.1038/nrm1744, 16227977.
41. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956. 10.1016/j.cell.2005.08.020, 3006442, 16153702.
42. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147:358-369. 10.1016/j.cell.2011.09.028, 3234495, 22000014.
43. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465:1033-1038. 10.1038/nature09144, 3206313, 20577206.
44. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693. 10.1126/science.1192002, 2967777, 20616235.
45. Tattermusch A, Brockdorff N. A scaffold for X chromosome inactivation. Hum Genet 2011, 130:247-253. 10.1007/s00439-011-1027-4, 21660507.
46. Chaumeil J, Le Baccon P, Wutz A, Heard E. A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes Dev 2006, 20:2223-2237. 10.1101/gad.380906, 1553206, 16912274.
47. Song X, Wang B, Bromberg M, Hu Z, Konigsberg W, Garen A. Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an immunodeficient mouse model. Proc Natl Acad Sci U S A 2002, 99:6269-6273. 122938, 11959915.
48. Meric C, Goff SP. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J Virol 1989, 63:1558-1568. 248388, 2926863.
49. Wolf D, Goff SP. Embryonic stem cells use ZFP809 to silence retroviral DNAs. Nature 2009, 458:1201-1204. 10.1038/nature07844, 2676211, 19270682.
50. Wolf D, Goff SP. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 2007, 131:46-57. 10.1016/j.cell.2007.07.026, 17923087.
51. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 2011, 107:21931-21936.
52. Pepke S, Wold B, Mortazavi A. Computation for ChIP-seq and RNA-seq studies. Nat Methods 2009, 6:S22-S32. 10.1038/nmeth.1371, 19844228.
53. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008, 5:621-628. 10.1038/nmeth.1226, 18516045.
54. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009, 10:R25. 10.1186/gb-2009-10-3-r25, 2690996, 19261174.